IJSER. (2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide [Entacapone] 7

Similar documents
Validated Stability-indicating assay method for determination of Ilaprazole in bulk drug and tablets by high performance liquid chromatography

Available Online through (or) IJPBS Volume 2 Issue 3 JULY-SEPT Research Article Pharmaceutical Sciences

RP-HPLC METHOD FOR QUANTITATIVE ESTIMATION OF GLATIRAMER ACETATE FOR INJECTION IN PHARMACEUTICAL DOSAGE FORMS

Quality-by-Design-Based Method Development Using an Agilent 1290 Infinity II LC

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON ARTEMETHER AND LUMEFANTRINE CAPSULES REVISED DRAFT FOR DISCUSSION

Research Paper Development of Stability Indicating Reverse Phase HPLC Method for Aripiprazole from Solid Dosage form

International Journal of Pharma Research & Review, Feb 2014; 3(2):11-16 ISSN:

Quantitative determination of residual 2-(2-chloroethoxy) ethanol (CEE) in quetiapine fumarate by gas chromatogaraphy

Size Exclusion Chromatography of Biosimilar and Innovator Insulin Using the Agilent AdvanceBio SEC column

A green HPLC technique with a 100% water mobile phase for detecting imidacloprid and its metabolite 6-chloronicotinic acid

Peptide Mapping: A Quality by Design (QbD) Approach

Chem 321 Lecture 23 - Liquid Chromatography 11/19/13

Heart-cut 2D-LC/MS approach for pharmaceutical impurity identification using an Agilent 6540 Q-TOF LC/MS System

QbD approach for analytical method development of anti-pschotic drug

Preparative HPLC is still the

Disulfide Linkage Analysis of IgG1 using an Agilent 1260 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column

Development & Validation of RP-HPLC Method for Estimation of Dabigatran Etexilate Mesylate from Capsule Dosage Form

Fast Preparative Column Liquid Chromatography (PCLC)

Quantification of Drug Metabolites in Early-Stage Drug Discovery Testing

Method Translation in Liquid Chromatography

APPLICATIONS TN Overview of Kinetex 2.6 µm Core-Shell Technology

Optimizing the Purification of a Standard Chiral Compound Utilizing a Benchtop, Multi-Purpose, Semi-Preparative to Preparative HPLC System

HPLC METHODOLOGY MANUAL

ANALYTICAL METHOD DEVELOPMENT FOR IMPURITIES PRESENT IN HYDROXY CHLOROQUINE SULPHATE FROM ANTIMALARIAL TABLET FORMULATION

Certified Reference Material - Certificate of Analysis

Improving Resolution and Column Loading Systematically in Preparative Liquid Chromatography for Isolating a Minor Component from Peppermint Extract

Technical Overview. Author. Abstract. Edgar Naegele Agilent Technologies, Inc. Waldbronn, Germany

Concentration of Human Hormones in Drinking Water Using Solid Phase Extraction and Analysis by High Performance Liquid Chromatography

VICH Topic GL2 (Validation: Methodology) GUIDELINE ON VALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY

Agilent AdvanceBio SEC Columns for Aggregate Analysis: Instrument Compatibility

DETERMINATION OF MYCOTOXINE DEOXYNIVALENOL IN WHEAT FLOUR AND WHEAT BRAN

Protein-Pak Hi Res HIC Column and HIC Protein Standard

Bioanalytical method validation: An updated review

Method Development and Validation for Online UV-Dissolution Methods Using Fiber-Optic Technology

Maximizing Chromatographic Resolution of Peptide Maps using UPLC with Tandem Columns

Qualification of High-Performance Liquid Chromatography Systems

Application Note. Author. Abstract. Biopharmaceuticals. Verified for Agilent 1260 Infinity II LC Bio-inert System. Sonja Schneider

Genotoxicity is the property of a compound

A Modular Preparative HPLC System for the Isolation of Puerarin from Kudzu Root Extracts

PAHs in Surface Water by PDA and Fluorescence Detection

Gas Chromatography Assignment Chem 543/443

Investigation of Solid Phase Microextraction as an Alternative to Dried Blood Spot

HIC as a Complementary, Confirmatory Tool to SEC for the Analysis of mab Aggregates

Method development and validation for the quantitative estimation of cefixime and ofloxacin in Pharmaceutical preparation by RP- HPLC

Analytical Methods Development and Validation

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

Developing Robust and Efficient IEX Methods for Charge Variant Analysis of Biotherapeutics Using ACQUITY UPLC H-Class System and Auto Blend Plus

EtG / EtS Analysis UCT INNOVATION THROUGH CHEMISTRY FORENSICS

Fundamentals and Techniques of Preparative HPLC. Parto Zist Behboud Tel: 42108

Improved SPE for UPLC/MS Determination of Diquat and Paraquat in Environmental

Saudi Journal of Medical and Pharmaceutical Sciences. Research Article. Available Online: 70

HPLC to UPLC Method Migration: An Overview of Key Considerations and Available Tools

Preparative HPLC: Factors and Parameters that Directly Affect Recovery of Collected Fractions

N. Tamilselvi *, Dona Sara Kurian. Department of Pharmaceutical Analysis. KMCH college of pharmacy Coimbatore

New Core-Shell Technology

Characterization of mab aggregation using a Cary 60 UV-Vis Spectrophotometer and the Agilent 1260 Infinity LC system

Developing and Validating Dissolution Procedures for Improved Product Quality

Laboratory Reagents. for life science research.

EPA Method 543: Selected Organic Contaminants by Online SPE LC/MS/MS Using the Agilent Flexible Cube

Development of Quality Control Method for Dissolution Analysis of Tapentadol and paracetamolin tablet

A Validated Stability Indicating HPTLC Method for Determination of Cephalexin in Bulk and Pharmaceutical Formulation

Forced Degradation of Ibuprofen in Bulk Drug and Tablets

Fast and High-Resolution Reversed-Phase Separation of Synthetic Oligonucleotides

Analysis of USP <467> Residual Solvents using the Agilent 7697A Headspace Sampler with the Agilent 7890B Gas Chromatograph

International Journal of Medicine and Nanotechnology

Novel Rp-Hplc-Pda Method for the Simultaneous Estimation of Metoprolol Succinate and Chlorthalidone in Bulk and Pharmaceutical Dosage Forms

Research Article. Optimization and validation of rapid and simple method for determination of Isoniazid and Pyrazinamide in plasma by HPLC-UV

Int. J. Pharm. Sci. Rev. Res., 31(1), March April 2015; Article No. 20, Pages: Comparison of UPLC with UFLC: Liquid Chromatography

A Fast and Effective Approach for Running EPA Method 539: Determination of Hormones in Drinking Water using SPE and LC/MS/MS

AppNote 5/2006 ABSTRACT

Protocol for Quantitative Determination of Residual Solvents in Cannabis Concentrates Prepared by: Amanda Rigdon, May 23 rd, 2016

Real-time tablet API analysis: a comparison of a palm-size NIR spectrometer to HPLC method

Determination of Adenovirus pviii (31K) Concentration for Estimation of the Empty Capsid Concentration of the Adenovirus Reference Material (ARM)

Bivalirudin Purification:

Application note. Guideline for validation of analytical methods using Cedex Bio, Cedex Bio HT, and Cedex HiRes Analyzers.

Application Note. Author. Abstract. Small Molecule Pharmaceuticals. Sonja Krieger Agilent Technologies, Inc. Waldbronn, Germany

Generating Automated and Efficient LC/MS Peptide Mapping Results with the Biopharmaceutical Platform Solution with UNIFI

PART II: SAMPLING AND SALIVA SAMPLE PRETREATMENT

Accucore. Ultimate Core Performance LC Column Technology to Maximize Your Investment. Dave Jarzinski. October 2011

Formulas: See Table 1 MW: Table 1 CAS: Table 1 RTECS: Table 1. METHOD: 2555, Issue 1 EVALUATION: PARTIAL Issue 1: 15 March 2003

Rapid Soft Spot Analysis using the SCIEX Routine Biotransform Solution

The Right Analytical Method for the Right Application: TOC Analysis for Cleaning Validation

The Analysis of 4-Vinyl-Cyclo-Hexene (VCH) in Butadiene with the DVLS LGI Injector

[ product solution ] Waters Oasis µ Elution PlateS. Patented Innovation. Elution volume as low as 25 μl. No evaporation and reconstitution

C196-E067A. Prominence UFLCXR. Shimadzu Ultra Fast Liquid Chromatograph

IMPURITIES. Antony Fake API Focal Point, PQTm WHO PREQUALIFICATION TEAM MEDICINES

Agilent 1220 Infinity II LC GET ON THE FAST TRACK TO HIGHEST EFFICIENCY AT A PRICE YOU CAN AFFORD

Agilent MetaCarb Ca PLUS Carbohydrate Column Ca ++ Form User Manual Part No. A5205

Polyvidone Polyvinylpyrrolidone H 2 C H C N

Fusion Analytical Method Validation

Agilent 6430 Triple Quadrupole LC/MS System

LC/MS. Why is it the fastest growing analytical technique?

Validation Report 19

Standardization of drying and extraction techniques for better colchicine recovery from Gloriosa superb

Application of USP Apparatus 7 to In Vitro Drug Release in Scopolamine Transdermal Systems

BÜCHI Labortechnik AG

Update to USP <621> Chromatography: What does this mean? USP 37 NF 32 1S Current as of August 2014

Exploring Extra Sensitivity Using ionkey/ms with the Xevo G2-XS Q-Tof HRMS for Small Molecule Pharmaceutical Analysis in Human Plasma

mab Titer Analysis with the Agilent Bio-Monolith Protein A Column

A universal chromatography method for aggregate analysis of monoclonal antibodies

Transcription:

International Journal of Scientific & Engineering Research, Volume 5, Issue 2, February-2014 462 Assay Method of Active Pharmaceutical Ingredient Entacapone by High Performance Liquid Chromatographic Technique Abstracts: Shashikant Aswale, Sunanda Aswale, Sachin Zade, Padma There, Rajesh Hajare and Aparna Dhote Lokmanya Tilak Mahavidyalaya, Wani, Dist. Yavatmal, 445 304 (MS). N. Shinde College, Bhadravati, Dist, Chandrapur, (MS) A simple, linear and reproducible assay method was developed for the quantification of entacapone API by using high performance liquid chromatography. The method was developed by using Phenomenox Kinetex C18, (100 x 4.6) mm, 2.6 micron column. Mobile phase consisted of Water: Methanol: Orthrophosphoric acid in ratio 50:50:0.1 with flow rate of 1.0 ml/min at 300 nm and column oven temperature at 50 C. RSD for standard preparation under system precision was observed 0.10%. RSD for retention time was observed 0.15% which shows reproducibility during replicate injections. The linearity range was achieved from 200 to 600 ppm level for entacapone. Comparative data of method and intermediate precision shows average assay value 99.81% on as is basis. The method was applied for quantification of assay of entacapone API. Key words: HPLC Assay, Entacapone API. Introduction: transferase (COMT) enzyme. It contains two stereoisomeric High performance liquid chromatography (HPLC) forms E = trans-isomer and the Z = cis-isomer. The E- is a worldwide accepted technique used for analysis of isomer was selected because of early synthetic route. drug substance, drug product and quantification of known Entacapone is rapidly absorbed from the gastro-intestinal as well as unknown impurities at lower level 1. Entacapone tract and undergoes extensive first pass metabolism. API is nitrocatechol derivative and it is used for treatment Entacapone is converted to its (cis)-isomer i.e. Z- of Parkinson s disease. Entacapone should be used in entacapone, the main metabolite in plasma followed by combination with levodopa. It is film coated tablet direct glucuronidation to inactive glucuronide conjugates. containing 200 mg Entacapone API in one tablet. Maximum Elimination of this conjugates is mainly via urine as recommended daily dose for adults is 2000 mg per day if necessary. Parkinson s disease is a neurodegenerative, slow progressive disorder, resting tremor, rigidity and postural glucuronide conjugates and Z- isomer 2. A HPLC method for Entacapone was published by T. Wikberg 3 and Ramakrishna 4 from rats and humans. The quantification reflex impairment with associated characteristic method was reported by Siddiqui 5 and Sivasubramanian 6 eosinophilic cytoplasmatic inclusions. Entacapone is orally for this drug. taken medicine which contains effect of a selective and reversible inhibitory effect on catechol-o-methyl (2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide [Entacapone] 7 Current work presents assay quantification method by HPLC to quantify entacapone API against standard.

International Journal of Scientific & Engineering Research, Volume 5, Issue 2, February-2014 463 Experimental: HPLC grade methanol as a solvent (Spectrochem), orthrophosphoric acid AR grade (Rankem) and HPLC grade water (Merck) were used. Entacapone test sample was received from Ramdev Chemical as a free sample. Z- Isomer of Entacapone is procured from LGC Promochem India limited. HPLC instrument of make Shimadzu LC 2010C HT with a quaternary gradient pump system and a fixed dual wavelength UV detector having LC-solution software with auto sampler tray with cooling facility and column oven temperature compartment is available was used for measurements. Development of method was initiated by keeping aim to develop simple isocratic, easy setup of experimentation and cost effective short run time assay quantification HPLC method for entacapone API, in such a way that we will get accurate and reproducible results in short period of time. The referred USP method-2 8 method was not found suitable in terms of composition of mobile phase 8. Tekale et al 9 also extend the research for quantification from tablet. Short length, lower micron size C18 column was selected to reduce run time and to achieve excellent separation with sharp peak shapes. Because of short length compound eluted faster and C18 carbon load in column helps for separation and lower particle size column gives sharp peaks as well as more separation. Column oven temperature study was performed in order to reduce the backpressure of column ensuring that it does not impact on separation. Some basic compounds have property to get retained in column and because of such compounds get stuck inside the column and when they eluted it gives more tailing to peak. In this case higher column oven temperature increases kinetic energy of compound for early elution with good separation and symmetric peak shape will be obtained. Also it reduces viscosity of mobile phase which helps to reduce the back pressure of column. In our method mobile phase is also easy to setup, which was premixed and degassed solution of HPLC grade water: Methanol: Orthrophosphoric acid in ratio 50:50:0.1 was used. Run time was kept 7 minutes and 5 micro liter injection volume was injected to avoid excess of sample loading on column. Since excess sample loading on column baseline may get disturbed, hump and broad peak shape may not observed. Mobile phase and other working solutions were filtered through 0.45 micron membrane filter and degassed by sonication. Slowly the flow rate was increased to achieve the column oven temperature and equilibrate column in mobile phase. Direct application of flow rate creates high pressure on column and may damage it. Diluent (water: methanol 50:50) was injected as blank preparation. No peak was observed in blank preparation at retention time of entacapone means there is no any blank interference. Five replicate injections of standard preparation were injected for calculation of % RSD. Chromatographic conditions: Column name : Phenomenox Kinetex C18, (100 x 4.6) mm, 2.6 micron Flow rate : 1.0 ml/min Wavelength : 300 nm Column Oven temperature : 50 C Run time : 7 minutes. Injection volume : 5 µl Mobile phase : Water: Methanol: Orthrophosphoric acid (50:50:0.1) Diluent : Water: Methanol (50:50) Results and discussion: a) Chromatography: Standard stock solution of entacapone was prepared by weighing accurately 50 mg of entacapone standard in 50 ml standard volumetric flask. 25 ml of methanol was added and sonicated to dissolve and volume was made up to mark with water. Thus 1000 ppm of Entacapone Stock solution was prepared. Further 10 ml of this solution was diluted to 25 ml volumetric flask and made up to mark with diluent. (400 ppm standard solution).

International Journal of Scientific & Engineering Research, Volume 5, Issue 2, February-2014 464 Figure: - 1 Chromatogram of Standard preparation Figure: - 2 Chromatogram of Spike preparation From the chromatogram (Fig. 1) it was concluded that the Retention time for Entacapone was 2.7 ± 0.05 minutes and tailing factor was 1.32 which as per USP should not be more than 1.5. Refer figure 2 is spike chromatogram of Z isomer, intermediate with entacapone API. It shows that impurity and intermediate is separated from entacapone peak. Where 3, 4-dihydroxy-5- nitrobenzaldehyde is an intermediate and Z isomer is impurity in entacapone. During method development it has to ensure that no any known as well unknown impurity especially any intermediate or raw material from which the product is synthesized should get merged with concern peak. If such peak gets merged then peak area of such peak will also get contributed in concerned peak area and incorrect results will be obtained. In the present work system precision performed by injecting five replicate injections of standard preparation and percent RSD was calculated. Table 1 refers to retention time and % RSD of standard area.

International Journal of Scientific & Engineering Research, Volume 5, Issue 2, February-2014 465 Table- 1: System precision Sr.No RT (min) Area 1 2.761 7547024 2 2.764 7538672 3 2.763 7539123 4 2.768 7527813 5 2.771 7530300 Average 2.76 7536586 % RSD 0.15 0.10 Linearity was performed from 50% to 150% level with respect to test concentration level in which linearity range was covered from 200 ppm to 600 ppm level. It was concluded that linearity graph that test concentration is linear and observed value for correlation coefficient is 0.9997. Linearity10 is an important parameter in validation which needs to be performed to obtain test results which are directly proportional to the concentration of analyte in test sample (Figure 3). Figure: 3 Linearity graph Reproducibility of method was checked by performing method precision in which same test preparation was performed six times and each of the preparations was injected in duplicate. Results were calculated against average area of five replicate injections of standard preparation. Reproducibility of method was checked by performing intermediates precision, in which same experiment was performed by different worker, different days etc. From the data obtained it is concluded that our method is reproducible. This is depicted in table 2 for comparative results. Table: 2 Comparison between method precision and intermediate precision. Sr.No Method Precision Intermediate Precision 1 99.8% 100.6% 2 99.6% 100.0% 3 99.8% 100.1% 4 99.7% 99.9% 5 99.3% 99.2% 6 100.2% 99.5% Average 99.81%

International Journal of Scientific & Engineering Research, Volume 5, Issue 2, February-2014 466 % RSD 0.39% Robustness 11 of method was checked by changing mobile phase composition, column oven temperature and flow rate and found method is robust in all condition and there is no merging of any peaks and peak shapes is also found good. The evaluation of robustness should be considered during the development phase and depends on the type of procedure under study. It should show the reliability of an Conclusion: The elution of entacapone standard was carried out on Kinetex C18, 4.6 100 mm x 2.6 micron column HPLC column, at the flow rate of 1 ml/min in isocratic mode using the mobile phase consisting of Water: Methanol: Orthrophosphoric acid (50:50:0.1) with flow rate of 1 ml/min at 300 nm. The method precision and intermediate precision of the method was calculated in terms of the relative standard deviation and it was observed 0.39% which analysis with respect to deliberate variations in method parameters. Stability of analytical solution was checked and found that it is stable up to 21 hrs at room temperature. For that freshly prepared solution injected and same solution kept at room temperature and injected after 21 hrs. Area difference found within acceptance criteria. indicates accurate reproducibility of method. Linearity graph plotted against average area Vs concentration which is found linear with correlation coefficient 0.9997 The method can be used successfully for identification and quantification of the active pharmaceutical ingredient entacapone from pharmaceutical ingredient. Hence this method can be used for the routine analysis of entacapone. Acknowledgement: The author is very much thankful to Dr. Gujar, Principal Sinhgad college of Pharmacy, wadgaon (BK) Pune for providing research laboratory as well as necessary facility. References: 1. Chitlange SS, Imran M, Sakarkar DM. 2008, Asian Journal of Pharmaceutics. 2 (4): 232-234. 2. Novartis Europharm Limited ; EU/1/98/081/001-003 3. Karlsson M. and Wikberg T. 1992, Journal of Pharmaceutical and Biomedical Analysis 10 (8): 563-600. 4. Ramakrishna NVS, Vishwottam KN, Wishu S, Koteshwara M and Chidambara, J. 2005, J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 23(2): 189 194. 5. Siddiqui et. al. (Siddiqui 2005) 6. Siddiqui, MJM, Khan RAR and RP Yadav 2005, USPTO 5, 584, 100. 7. Drug bank, DB00494 (APRD00416) 8. USP Volume 36(2), 396. 9. Prafullachandra Tekale, Vinayak S Mhatre, N R Pai, Chandrabhanu Maurya and Smruti Tekale, Bioscience Discovery, 2 (3):294-298, July 2011. 10. ICH guidelines for Validation of analytical procedures: Text and methodology Q2 (R1), (step 4 version), 8. 11. ICH guidelines for Validation of analytical procedures: Text and methodology Q2 (R1), (step 4 version), 13.